Related Experiment Video
Updated: Jun 10, 2026

Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin
Published on: December 23, 2010
Leukotrienes: Novel targets for vascular disease
1James Graham Brown Cancer Center and the Department of Microbiology and Immunology, University of Louisville Health Sciences Center, 580 South Preston Street, Louisville, KY 40202, USA.
Atherosclerosis, a leading cause of death, involves arterial inflammation and cholesterol buildup. Monocyte recruitment and oxidized LDL uptake initiate foam cell formation, driving disease progression.
Area of Science:
- Cardiovascular Science
- Immunology
- Pathology
Background:
- Atherosclerosis is a major cause of death globally, responsible for heart attacks and strokes.
- Increased serum cholesterol, particularly oxidized low-density lipoproteins (LDL), is a primary risk factor.
- Atherosclerosis is increasingly recognized as an inflammatory vascular disease with poorly understood molecular mechanisms.
Purpose of the Study:
- To elucidate the molecular events initiating and driving atherosclerosis development.
- To understand the role of monocyte recruitment and oxidized LDL in disease pathogenesis.
Main Methods:
- This abstract does not detail specific methods.
- The text describes the proposed sequence of events in atherosclerosis development.
Main Results:
- Monocyte recruitment to arterial walls is identified as a potential initiating step.
- Uptake of oxidized LDL by monocytes leads to foam cell formation, a key pathological feature.
Conclusions:
- Understanding the inflammatory and molecular pathways of atherosclerosis is crucial.
- Targeting monocyte recruitment and oxidized LDL metabolism may offer therapeutic strategies.
More Related Videos
12:50Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
Related Concept Videos
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...